A phase II, open label, uncontrolled, multi center study to evaluate safety and immunogenicity of an adjuvanted influenza vaccine surface antigen, inactivated, formulation 2007-2008, when administered to non-elderly adult and elderly subjects.

Trial Profile

A phase II, open label, uncontrolled, multi center study to evaluate safety and immunogenicity of an adjuvanted influenza vaccine surface antigen, inactivated, formulation 2007-2008, when administered to non-elderly adult and elderly subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Nov 2011

At a glance

  • Drugs Adjuvants; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 15 Nov 2011 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
    • 19 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top